The stratified analysis on GH treatment shows that osteoporosis/osteopenia, hypercholesterolemia, DM2, obesity and hypertension rates are higher in adults who never received GH treatment (Table 3). This evidence concerns the gene GH1 and myotonic dystrophy type 2.